Drug profile · INN
uridine triacetate
XURIDEN
uridine triacetate (XURIDEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — uridine triacetate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
uridine triacetate (XURIDEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN uridine triacetate
Brand XURIDEN
Mechanism Unknown
Route ORAL
Formulation GRANULE
Mechanism of action
Unknown
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is uridine triacetate?
uridine triacetate (XURIDEN) is a unknown. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for uridine triacetate?
XURIDEN is a marketed brand name for uridine triacetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of uridine triacetate?
uridine triacetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.